ORCID

0009-0003-8803-9574

Date of Award

Spring 4-15-2025

Document Type

Thesis

Degree Name

Doctor of Nursing Practice (DNP)

Department

Nursing

Advisor

Dr. Kirk Hummer

First Committee Member

Dr. Kirk Hummer

Second Committee Member

Dr. Brian Garrett

Third Committee Member

Dr. Amy Bishop

Keywords

type 1 diabetes, type 2 diabetes, EBP guidelines, insulin pump, perioperative, hyperglycemia, hypoglycemia

Subject Categories

Medicine and Health Sciences | Perioperative, Operating Room and Surgical Nursing | Quality Improvement

Abstract

According to the International Diabetes Federation, Diabetes Mellitus (DM) affects approximately 537 million people, representing approximately 10% of the worldwide population aged 20 to 79. Approximately 400,000 people with DM use continuous subcutaneous insulin infusion (CSII) pumps. CSII pump therapy mimics pancreatic insulin release, aiding in maintaining adequate insulin levels. Individuals with DM are more likely to require surgery than individuals without the disease. Among diabetics, people with Type 1 DM (T1D) are more likely to need medical interventions than individuals with Type 2 DM (T2DM). CSII therapy maintains blood glucose levels within a programmed range and decreases blood glucose level variability. When surgery is needed for patients with DM, a decision must be made to continue or discontinue CSII pump function during surgery. Many facilities lack guidelines related to perioperative CSII pump usage and glycemic control during the perioperative period. Nationally, there is an absence of guidelines from professional organizations guiding the anesthesia provider on perioperative CSII pump operation. The project team reviewed available literature to create a set of evidence-based practice (EBP) guidelines for perioperative CSII pump usage and glycemic control during the perioperative period. These EBP guidelines give the anesthesia provider information to guide the management of CSII pump therapy during the perioperative period. Guidance is provided to assist the anesthesia provider with pump management, restrictions, contraindications, imaging, CSII pump alarms and malfunctions, and CSII pump therapy discontinuation. This final scholarly project will not be implemented.

Keywords: type 1 diabetes, type 2 diabetes, EBP guidelines, insulin pump, perioperative, hyperglycemia, hypoglycemia

Acknowledgement 1

1

Acknowledgement 2

1

Licensing Permission

Copyright, all rights reserved. Fair Use

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.